Crossject (ALCJ) EUR1

Sell:€1.86Buy:€2.00€0.04 (2.08%)

Prices delayed by at least 15 minutes
Sell:€1.86
Buy:€2.00
Change:€0.04 (2.08%)
Prices delayed by at least 15 minutes
Sell:€1.86
Buy:€2.00
Change:€0.04 (2.08%)
Prices delayed by at least 15 minutes

Company Information

About this company

Crossject SA is a France-based company that designs and develops medical injection systems. The Company specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous, and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The Company's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance, and comfort. The Company has industrial partnerships with Hirtenberger and Recipharm. It provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.

Key people

Philippe Monnot
Chairman of the Supervisory Board
Patrick Alexandre
Chairman of the Management Board, Co-Founder
Dan Chiche
Chief Medical Officer
Henri De Parseval
Member of the Management Board
Olivier Gire
Member of the Management Board
Isabelle Liebschuetz
Member of the Management Board
Eric Nemeth
Independent Vice Chairman of the Supervisory Board
Patrice Coissac
Member of the Supervisory Board
Jean-Francois Loumeau
Member of the Supervisory Board
Yannick Pletan
Member of the Supervisory Board
Daniel G. Teper
Member of the Supervisory Board
Click to see more

Key facts

  • EPIC
    -
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    FR0011716265
  • Market cap
    €87.53m
  • Employees
    112
  • Shares in issue
    41.28m
  • Exchange
    Euronext Paris
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.